Therapeutic drug monitoring of voriconazole and CYP2C19 phenotype for dose optimization in paediatric patients

被引:0
|
作者
Lin Hu
Qi Huang
Shiqiong Huang
Zeying Feng
机构
[1] the First Hospital of Changsha,Department of Pharmacy
[2] Xiangya Hospital,Department of Pharmacy
[3] Central South University,Clinical Trial Institution Office
[4] Liuzhou Hospital of Guangzhou Women and Children’s Medical Center,Center of Clinical Pharmacology
[5] the Third Xiangya Hospital,undefined
[6] Central South University,undefined
关键词
Voriconazole; Therapeutic drug monitoring; CYP2C19 phenotype; Paediatric patients;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1271 / 1278
页数:7
相关论文
共 50 条
  • [1] Therapeutic drug monitoring of voriconazole and CYP2C19 phenotype for dose optimization in paediatric patients
    Hu, Lin
    Huang, Qi
    Huang, Shiqiong
    Feng, Zeying
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 79 (09) : 1271 - 1278
  • [2] Voriconazole therapeutic drug monitoring including analysis of CYP2C19 phenotype in immunocompromised pediatric patients with invasive fungal infections
    Resztak, Matylda
    Zalewska, Paulina
    Wachowiak, Jacek
    Sobkowiak-Sobierajska, Agnieszka
    Glowka, Franciszek K.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 80 (11) : 1829 - 1840
  • [3] Therapeutic drug monitoring and CYP2C19 genotyping guide the application of voriconazole in children
    Chen, Xiaomin
    Xiao, Yuhua
    Li, Huiping
    Huang, Zhi
    Gao, Jingyu
    Zhang, Xinyao
    Li, Yirong
    Van Timothee, Bindanda Mvuama
    Feng, Xiaoqin
    TRANSLATIONAL PEDIATRICS, 2022, 11 (08) : 1311 - 1322
  • [4] Why are the Therapeutic Drug Monitoring Results of Voriconazole Inconsistent with CYP2C19 Genetic Testing?
    Kong, Lingti
    Xie, Mengyuan
    Jiang, Manxue
    Zhu, Yulin
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2023, 33 (05): : 598 - 599
  • [5] Impact of CYP2C19 Phenotype and Drug-Drug Interactions on Voriconazole Concentration in Pediatric Patients
    Tian, Xueke
    Zhang, Congmin
    Qin, Zifei
    Wang, Dao
    Yang, Jing
    Zhang, Xiaojian
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (09)
  • [6] CYP2C19 Polymorphisms and Therapeutic Drug Monitoring of Voriconazole: Are We Ready for Clinical Implementation of Pharmacogenomics?
    Obeng, Aniwaa Owusu
    Egelund, Eric F.
    Alsultan, Abdullah
    Peloquin, Charles A.
    Johnson, Julie A.
    PHARMACOTHERAPY, 2014, 34 (07): : 703 - 718
  • [7] Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activity
    Bouatou, Yassine
    Samer, Caroline Flora
    Lorenzini, Kuntheavy Roseline Ing
    Daali, Youssef
    Daou, Samira
    Fathi, Marc
    Rebsamen, Michela
    Desmeules, Jules
    Calmy, Alexandra
    Escher, Monica
    AIDS RESEARCH AND THERAPY, 2014, 11
  • [8] Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activity
    Yassine Bouatou
    Caroline Flora Samer
    Kuntheavy Roseline Ing Lorenzini
    Youssef Daali
    Samira Daou
    Marc Fathi
    Michela Rebsamen
    Jules Desmeules
    Alexandra Calmy
    Monica Escher
    AIDS Research and Therapy, 11
  • [9] A case report of voriconazole therapeutic drug monitoring in a heterozygous ultrarapid CYP2C19*1/*17 patient
    Quaranta, S.
    Scodavolpe, S.
    Corda, E. D'incan
    Saut, N.
    Berger, P.
    Morange, P. E.
    Lacarelle, B.
    Solas, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 68 - 69
  • [10] Correlation of CYP2C19 Phenotype With Voriconazole Plasma Concentration in Children
    Narita, Atsushi
    Muramatsu, Hideki
    Sakaguchi, Hirotoshi
    Doisaki, Sayoko
    Tanaka, Makito
    Hama, Asahito
    Shimada, Akira
    Takahashi, Yoshiyuki
    Yoshida, Nao
    Matsumoto, Kimikazu
    Kato, Koji
    Kudo, Kazuko
    Furukawa-Hibi, Yoko
    Yamada, Kiyofumi
    Kojima, Seiji
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2013, 35 (05) : E219 - E223